Summary.-Benz(a)anthracene injected subcutaneously during the first 3 days of life caused a dose related increase in the incidence of liver and lung tumours in Swiss mice but over a similar dose range, the K region epoxide of benz(a)anthracene was less effective. Neonatally injected 7-methylbenz(a)anthracene was considerably more active than its K region epoxide in increasing the incidence of liver tumours in males. Both the parent compound and the epoxide slightly raised the incidence of lung tumours. Both chrysene and its K region epoxide increased liver tumour incidence but not lung tumour incidence. The K region epoxides of dibenz(a,h) -anthracene and 3-methylcholanthrene were without apparent effect on the incidence of liver, lung or other tumours despite indications from previously reported studies that the parent hydrocarbons are active at the same dose levels. The K region epoxide of phenanthrene had no effect on the incidence of any kind of neoplasm.
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THE HYPOTHESIS that the carcinogenicity of polycyclic hydrocarbons is associated with the formation of epoxide metabolites Sims, 1971, 1972; Keysell et al., 1973 ) is supported by some experimental evidence but remains unproven. The original comparative carcinogenicity data from 3 laboratories showed that K region epoxides were less potent than the parent hydrocarbons either when applied topically or when administered subcutaneously (Boyland and Sims, 1967; Sims, 1967; Miller and Miller, 1967; Van Duuren et al., 1967) . More recent studies with epoxides in 2 in vitro transformation systems (Berwald and Sachs, 1963; Chen and Heidelberger, 1969) have demonstrated that several K region derivatives are more active than the corresponding hydrocarbons in inducing malignant transformation Marquardt et al., 1972; Huberman et al., 1972) , but others are not (Marquardt et al., 1974) . The epoxides can also act as alkylating agents (Grover and Sims, 1970) and as mutagens (Ames, Sims and Grover, 1972; Huberman et al., 1971; Cookson, Sims and Grover, 1971; Fahmy and Fahmy, 1973) . Rapidly dividing cell populations, like those used in the in vitro transformation systems, might be expected to be more susceptible to reactive carcinogens, like epoxides, than mitotically inactive tissues if reactions with cellular constituents at a particular stage of the cell cycle are important (Bertram and Heidelberger, 1974; Marquardt, 1974) . The newborn mouse, which is susceptible to carcinogenic polycyclic hydrocarbons (Roe, Rowson and Salaman, 1961; Roe, Mitchley and Walters, 1963; Roe, 1964, 1966) can be considered as a convenient source of several types of rapidly dividing cells. Consequently we have tested the K region epoxides derived from phenanthrene, benz(a)anthracene, 7-methylbenz(a)anthracene, dibenz(a,h)-anthracene, chrysene and 3-methylcholanthrene, together with some of the parent hydrocarbons, for carcinogenicity using newborn mice. This paper presents the results that were obtained in these experiments.
MATERIALS AND METHODS
The polycyclic hydrocarbon epoxides, phenanthrene 9,10-oxide, benz(a)anthracene 5,6-oxide, 7-methylbenz(a)anthracene 5,6-oxide, dibenz(a,h)anthracene 5,6-oxide, chrysene 5,6-oxide and 3-methylcholanthrene 11,12-oxide were prepared from the parent hydrocarbons (Newman and Blum, 1964; Boyland and Sims, 1965; Sims 1966) .
Two experiments were undertaken following similar protocols. For each experiment Swiss mice from a specific pathogenfree colony were time mated so as to produce a large number of litters over the course of 2 or 3 days. Newvborn mice from each litter were randomly allocated to various treatment and control groups and 6 or 7 similarly treated baby mice derived from different litters returned to each mother mouse that had contributed her own litter to the pool.
Test compounds were suspended in polyethylene glycol (PEG) 400 and injections of 0-02 ml of the suspension were given by introducing a 25 gauge hypodermic needle through the skin near the root of the tail and threading it subcutaneously to deliver the injected material in the interscapular region. Injections were given to every mouse on the first day or first 3 days of life.
The details of treatments and numbers of mice of each sex in each group are shown in Table I terminated when surviving mice were between 70 and 75 weeks old. A full routine postmortem examination, which included distension of the urinary bladder with fixative, was carried out. The number of lesions thought to be neoplasms and the size of the largest such lesion in each organ affected were recorded.
All tissues with suspected neoplasms were fixed in Bouin's solution. Haematoxylin and eosin stained 5 ,um paraffin wax sections were prepared and examined microscopically.
RESULTS
The results of the two experiments in terms of tumour incidence are summarized in Tables II and IV. Comparison of benz(a)anthracene and its K region epoxide Benz(a)anthracene (Groups A, B and C) had a dose related effect on the incidence of liver tumours in male mice and of lung tumours in mice of both sexes. The effect on incidence was manifest in terms both of the proportion of animals killed between the 70th and 75th weeks of the experiment that had at least one tumour of either type and in terms of the proportion of such animals with multiple tumours of these types. In all 3 groups treated with benz(a)anthracene the incidence of both lung and liver tumours was higher than in mice exposed to the vehicle, PEG 400, only (Group G). By comparison, the epoxide of benz(a)-anthracene was less active than the parent compound. At the lowest level of dosage (Group F-3 x 50 ,tg) the incidence of the 2 kinds of tumour was not very different from that in Group G. At the 2 higher levels (Groups D and E) treatment was associated with an increase in incidence of liver tumours in males, but the effect was more marked in Group E than in Group D and it was only in Group E females that an increased incidence of lung tumours was apparent.
Histologically, the liver tumours were all of parenchymal cell origin, ranging in appearance from well differentiated liver cell masses that were difficult to distinguish from normal liver tissues to pleomorphic, invasive and metastasizing tumours. All the tumours shown in Table II It is concluded that the epoxide of benz(a)anthracene is less active than its parent compound in increasing liver and lung tumour incidence after parenteral administration during early neonatal life.
Comparison epoxide of chrysene and its K region
In Experiment II, the incidence of liver tumours in control male mice given 3 doses of PEG 400 at birth (Group 0) was 9 of 30 animals killed between 70 and 75 weeks. Of these, one had 2 liver tumours. This incidence is higher than in similarly treated mice (Group G) in Experiment I (4 of 22 male mice killed between 70 and 75 weeks, none with multiple liver tumours). Against this background incidence, however, chrysene (Group H) increased liver tumour incidence. Neither chrysene nor its K region epoxide affected the incidence of lung tumours and, if anything, the parent compound seemed to be more active than its epoxide.
Comparison of 7-methylbenz(a)anthracene and its K region epoxide In this case a striking difference was seen between the effects of the 2 compounds on liver tumour incidence in males. Most of the animals treated with the parent compound died, or had to be killed because they were sick, between the 50th and 70th week of the experiment. Nevertheless, a much higher incidence of liver tumours was encountered in these animals than in animals treated with the epoxide that were examined post mortem between the 70th and 75th week. The females of both groups exhibited a raised incidence of lung tumours and in this case the activity of the epoxide was not less than that of the parent compound.
K region epoxides of phenanthrene, dibenz-(a,h)anthracene and 3-methylcholanthrene In the doses tested, all 3 epoxides were without obvious effect on the incidence of liver, lung or other tumours. It is highly probable that the epoxides of dibenz(a,h)anthracene and 3-methylcholanthrene are less active than the parent compounds and that the epoxide of phenanthrene is as active as phenanthrene itself. Groups of mice treated with the 3 parent compounds were not included, however, in the present experiment.
DISCUSSION
The carcinogenic activity of some K region epoxides derived from polycyclic hydrocarbons has been tested in newborn mice partly because of the conflicting results that have previously been obtained from tests in adult animals and from in vitro malignant transformation systems. There are obvious difficulties associated with testing reactive intermediates like the hydrocarbon epoxides for carcinogenicity and it was thought that rapidly dividing neonatal tissues might offer some advantages over those of adult animals, especially if factors such as reactions with DNA at a critical stage of the cell cycle, DNA replication and DNA repair are involved in carcinogenesis. Additionally, neonatal tissues probably possess lower levels of the microsomal epoxide hydrase that catalyses the conversion of epoxides to dihydrodiols (Oesch, 1973 (Kelly and O'Gara, 1961) . The phenanthrene epoxide did not appear to enhance tumour incidence, which is not really surprising since the parent hydrocarbon is also inactive in newborn mice (Roe and Walters, 1967) .
In the metabolism of the polycyclic hydrocarbons, a variety of epoxides seem certain to be formed as the initial products of the oxidation of the aromatic double bonds, a process catalysed by the microsomal mono-oxygenases, and it is these epoxides that are now thought to be converted into the hydroxylated derivatives that are the main metabolites of the hydrocarbons. So far, most studies of hydrocarbon epoxides have been concentrated, for practical reasons, on K region epoxides, several of which have been detected as metabolites and prepared by synthesis, and this work has recently been reviewed . Although some K region epoxides were more active than the parent hydrocarbons in the induction of malignant transformation of cells in culture, most K region epoxides were found to be less carcinogenic in adult animals and, as reported here, are less active in newborn mice. In addition, in cells treated with 7-methylbenz(a)anthracene, the DNA products formed are different from those obtained with the corresponding K region epoxide (Baird et al., 1973) . On balance therefore, these findings can be inter. preted as meaning that K region epoxides are not the epoxide metabolites involved in hydrocarbon carcinogenesis. This is in accord with some very recent evidence which suggests that the DNA products that are formed in mammalian cells treated with polycyclic hydrocarbons arise from non-K region epoxides, which are themselves derived from dihydrodiols Swaisland et al., 1974) 
